Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (12328)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Oct 7, 2017 (publication date) through Dec 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pasarín M, Abraldes JG, Liguori E, Kok B, La Mura V. Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction. World J Gastroenterol 2017; 23(37): 6777-6787 [PMID: 29085222 DOI: 10.3748/wjg.v23.i37.6777] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v23/i37/6777.htm |
| Number | Citing Articles |
| 1 |
A A Shipovskaya, O P Dudanova, I V Kurbatova. The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease. Terapevticheskii arkhiv 2018; 90(8): 63 doi: 10.26442/terarkh201890863-68
|
| 2 |
Taraneh Faghihi Langroudi, Habib Haybar, Saeed Alipour Parsa, Mohamad Mahjoorian, Isa Khaheshi, Mohammadreza Naderian. The severity of coronary artery disease was not associated with non-alcoholic fatty liver disease in a series of 264 non-diabetic patients who underwent coronary angiography. Romanian Journal of Internal Medicine 2018; 56(3): 167 doi: 10.2478/rjim-2018-0009
|
| 3 |
P. V. Koroy, Yu. A. Kravchenko, A. V. Yagoda. The possibilities of soluble selectins in the prediction of severe fi brosis in nonalcoholic fatty liver disease. Experimental and Clinical Gastroenterology 2022; (3): 50 doi: 10.31146/1682-8658-ecg-199-3-50-56
|
| 4 |
Yan Lv, Nishant Patel, Hai-Jun Zhang. The progress of non-alcoholic fatty liver disease as the risk of liver metastasis in colorectal cancer. Expert Review of Gastroenterology & Hepatology 2019; 13(12): 1169 doi: 10.1080/17474124.2019.1697231
|
| 5 |
Doris Ogresta, Anna Mrzljak, Maja Cigrovski Berkovic, Ines Bilic-Curcic, Sanja Stojsavljevic-Shapeski, Lucija Virovic-Jukic. Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. Journal of Clinical and Translational Hepatology 2022; 10(2): 339 doi: 10.14218/JCTH.2021.00268
|
| 6 |
Adel Hammoutene, Pierre-Emmanuel Rautou. Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease. Journal of Hepatology 2019; 70(6): 1278 doi: 10.1016/j.jhep.2019.02.012
|
| 7 |
Atsushi Sato, Yusuke Yumita, Kazuki Kagami, Yuki Ishinoda, Toyokazu Kimura, Ayumu Osaki, Takumi Toya, Takayuki Namba, Shogo Endo, Yasuo Ido, Yuji Nagatomo, Yasushi Satoh, Takeshi Adachi. Endothelial Extracellular Signal‐Regulated Kinase/Thromboxane A2/Prostanoid Receptor Pathway Aggravates Endothelial Dysfunction and Insulin Resistance in a Mouse Model of Metabolic Syndrome. Journal of the American Heart Association 2022; 11(23) doi: 10.1161/JAHA.122.027538
|
| 8 |
Iulia Minciuna, Madalina Gabriela Taru, Bogdan Procopet, Horia Stefanescu. The Interplay between Liver Sinusoidal Endothelial Cells, Platelets, and Neutrophil Extracellular Traps in the Development and Progression of Metabolic Dysfunction-Associated Steatotic Liver Disease. Journal of Clinical Medicine 2024; 13(5): 1406 doi: 10.3390/jcm13051406
|
| 9 |
Miren Bravo, Imma Raurell, Diana Hide, Anabel Fernández-Iglesias, Mar Gil, Aurora Barberá, Maria Teresa Salcedo, Salvador Augustin, Joan Genescà, María Martell. Restoration of liver sinusoidal cell phenotypes by statins improves portal hypertension and histology in rats with NASH. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-56366-2
|
| 10 |
Olesia P. Balazh. ENDOTHELIUM DYSFUNCTION IN PATIENTS WITH LIVER CIRRHOSIS. Emergency Medical Service 2022; 9(3): 100 doi: 10.36740/EmeMS202202105
|
| 11 |
Xue-Kai Wang, Zong-Gen Peng. Targeting Liver Sinusoidal Endothelial Cells: An Attractive Therapeutic Strategy to Control Inflammation in Nonalcoholic Fatty Liver Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.655557
|
| 12 |
Eman M. EL-Shial, Amal Kabbash, Mona El-Aasr, Ola A. El-Feky, Suzy A. El-Sherbeni. Elucidation of Natural Components of Gardenia thunbergia Thunb. Leaves: Effect of Methanol Extract and Rutin on Non-Alcoholic Fatty Liver Disease. Molecules 2023; 28(2): 879 doi: 10.3390/molecules28020879
|
| 13 |
Shriram D. Ranade, Shankar G. Alegaon, Nayeem A. Khatib, Shankar Gharge, Rohini S. Kavalapure, B.R. Prashantha Kumar. Reversal of insulin resistance to combat type 2 diabetes mellitus by newer thiazolidinedione's in fructose induced insulin resistant rats. European Journal of Medicinal Chemistry 2024; 280: 116939 doi: 10.1016/j.ejmech.2024.116939
|
| 14 |
Murali Ganesan, Larisa Y Poluektova, Kusum K Kharbanda, Natalia A Osna. Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression. World Journal of Gastroenterology 2019; 25(4): 398-410 doi: 10.3748/wjg.v25.i4.398
|
| 15 |
Eudith Januario, Aly Barakat, Abhivanditha Rajsundar, Zahra Fatima, Varda Nanda Palienkar, Arjun V Bullapur, Sunchandandeep Singh Brar, Punam Kharel, Mishal Mohammed Koyappathodi Machingal, Amena Backosh. A Comprehensive Review of Pathophysiological Link Between Non-alcoholic Fatty Liver Disease, Insulin Resistance, and Metabolic Syndrome. Cureus 2024; doi: 10.7759/cureus.75677
|
| 16 |
Niklas Verloh, Ingo Einspieler, Kirsten Utpatel, Karin Menhart, Stefan Brunner, Frank Hofheinz, Jörg van den Hoff, Philipp Wiggermann, Matthias Evert, Christian Stroszczynski, Dirk Hellwig, Jirka Grosse. In vivo confirmation of altered hepatic glucose metabolism in patients with liver fibrosis/cirrhosis by 18F-FDG PET/CT. EJNMMI Research 2018; 8(1) doi: 10.1186/s13550-018-0452-y
|
| 17 |
Olga Bondareva, Jesús Rafael Rodríguez-Aguilera, Fabiana Oliveira, Longsheng Liao, Alina Rose, Anubhuti Gupta, Kunal Singh, Florian Geier, Jenny Schuster, Jes-Niels Boeckel, Joerg M. Buescher, Shrey Kohli, Nora Klöting, Berend Isermann, Matthias Blüher, Bilal N. Sheikh. Single-cell profiling of vascular endothelial cells reveals progressive organ-specific vulnerabilities during obesity. Nature Metabolism 2022; 4(11): 1591 doi: 10.1038/s42255-022-00674-x
|
| 18 |
Bayan Abdulhafid Aljahdali, Adnan Salem Bajaber, Doha M. Al-Nouri, Abdulrahman Saleh Al-Khalifah, Shaista Arzoo, Abeer Abdullah Alasmari. The Development of Nonalcoholic Fatty Liver Disease and Metabolic Syndromes in Diet-Induced Rodent Models. Life 2023; 13(6): 1336 doi: 10.3390/life13061336
|
| 19 |
Manna Li, Ming Qian, Kathy Kyler, Jian Xu. Adipose Tissue-Endothelial Cell Interactions in Obesity-Induced Endothelial Dysfunction. Frontiers in Cardiovascular Medicine 2021; 8 doi: 10.3389/fcvm.2021.681581
|
| 20 |
Marian A. Troelstra, Anne-Marieke Van Dijk, Julia J. Witjes, Anne Linde Mak, Diona Zwirs, Jurgen H. Runge, Joanne Verheij, Ulrich H. Beuers, Max Nieuwdorp, Adriaan G. Holleboom, Aart J. Nederveen, Oliver J. Gurney-Champion. Self-supervised neural network improves tri-exponential intravoxel incoherent motion model fitting compared to least-squares fitting in non-alcoholic fatty liver disease. Frontiers in Physiology 2022; 13 doi: 10.3389/fphys.2022.942495
|
| 21 |
Rostyslav Bubnov, Mykola Spivak. Microbiome in 3P Medicine Strategies. Advances in Predictive, Preventive and Personalised Medicine 2023; 16: 133 doi: 10.1007/978-3-031-19564-8_6
|
| 22 |
Shuo Yuan, Hua-Min Zhang, Jia-Xin Li, You Li, Qi Wang, Guang-Yao Kong, Ao-Han Li, Ji-Xing Nan, Ying-Qing Chen, Qing-Gao Zhang. Gasotransmitters in non-alcoholic fatty liver disease: just the tip of the iceberg. European Journal of Pharmacology 2023; 954: 175834 doi: 10.1016/j.ejphar.2023.175834
|
| 23 |
Mario Masarone, Valerio Rosato, Marcello Dallio, Antonietta Gerarda Gravina, Andrea Aglitti, Carmelina Loguercio, Alessandro Federico, Marcello Persico, Daniele Vergara. Role of Oxidative Stress in Pathophysiology of Nonalcoholic Fatty Liver Disease. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/9547613
|
| 24 |
Agostino Di Ciaula, Federico Carbone, Harshitha Shanmugham, Emilio Molina-Molina, Leonilde Bonfrate, Stefano Ministrini, Fabrizio Montecucco, Piero Portincasa. Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver. European Journal of Internal Medicine 2021; 89: 56 doi: 10.1016/j.ejim.2021.03.036
|
| 25 |
Emilio Molina-Molina, Harshitha Shanmugam, Agostino Di Ciaula, Ignazio Grattagliano, Domenica Maria Di Palo, Vincenzo O. Palmieri, Piero Portincasa. (13C)-Methacetin breath test provides evidence of subclinical liver dysfunction linked to fat storage but not lifestyle. JHEP Reports 2021; 3(1): 100203 doi: 10.1016/j.jhepr.2020.100203
|
| 26 |
Narjes Nasiri-Ansari, Theodoros Androutsakos, Christina-Maria Flessa, Ioannis Kyrou, Gerasimos Siasos, Harpal S. Randeva, Eva Kassi, Athanasios G. Papavassiliou. Endothelial Cell Dysfunction and Nonalcoholic Fatty Liver Disease (NAFLD): A Concise Review. Cells 2022; 11(16): 2511 doi: 10.3390/cells11162511
|
| 27 |
Luz M. Medrano, Pilar Garcia-Broncano, Juan Berenguer, Juan González-García, Ma Ángeles Jiménez-Sousa, Josep M. Guardiola, Manuel Crespo, Carmen Quereda, José Sanz, Isabel Canorea, Ana Carrero, Victor Hontañón, Ma Ángeles Muñoz-Fernández, Salvador Resino. Elevated liver stiffness is linked to increased biomarkers of inflammation and immune activation in HIV/hepatitis C virus-coinfected patients. AIDS 2018; 32(9): 1095 doi: 10.1097/QAD.0000000000001787
|